Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis.

Author: AntoniniA, AsgharnejadM, BauerL, BoroojerdiB, ChaudhuriK R, GriegerF, WeintraubD

Paper Details 
Original Abstract of the Article :
Dopamine agonists in Parkinson's disease (PD) are associated with impulse control disorders (ICDs) and other compulsive behaviours (together called ICD behaviours). The frequency of ICD behaviours reported as adverse events (AEs) in long-term studies of rotigotine transdermal patch in PD was evaluat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096013/

データ提供:米国国立医学図書館(NLM)

Dopamine Agonists: The Double-Edged Sword of Parkinson's Disease Treatment

This research delves into the complex relationship between dopamine agonists, a common treatment for Parkinson's disease, and impulse control disorders (ICDs). It's like exploring a desert landscape where seemingly beneficial resources can also have unexpected consequences. The researchers investigate the potential for dopamine agonists to trigger ICD behaviors in patients with Parkinson's disease, highlighting the need for careful monitoring and management.

Navigating the Side Effects of Parkinson's Disease Treatment

The study reveals that dopamine agonists, while effective in treating Parkinson's disease, can increase the risk of ICD behaviors in some patients. It's like discovering that a seemingly refreshing oasis can also harbor hidden dangers. This finding emphasizes the importance of understanding the potential side effects of medications and carefully monitoring patients for any changes in behavior or mental state.

Balancing Benefits and Risks in Parkinson's Disease Treatment

This research highlights the need for a balanced approach to Parkinson's disease treatment, considering both the benefits and risks of available medications. It's like finding a path through a desert where both the benefits and dangers must be carefully weighed. By being aware of the potential for ICD behaviors, healthcare providers can better manage patients and ensure that the benefits of treatment outweigh the risks.

Dr.Camel's Conclusion

Dopamine agonists are a valuable tool in treating Parkinson's disease, but it's crucial to be aware of their potential side effects. Just as a desert traveler must be prepared for the unexpected, healthcare providers must be vigilant in monitoring patients for any changes in behavior. By balancing the benefits of treatment with the risks, we can ensure a safer and more effective approach to managing Parkinson's disease.

Date :
  1. Date Completed 2017-12-19
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

27425586

DOI: Digital Object Identifier

PMC5096013

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.